ÂÜÀòÂÒÂ×

Ken d'Entremont is an experienced pharmaceutical executive currently serving as CEO of Medexus Pharmaceuticals Inc. since December 2018, a prominent specialty pharmaceutical company in North America. Prior to this role, Ken d'Entremont was President & CEO of Medexus Inc. from January 2000 to December 2018, overseeing a Canadian-based, privately held pharmaceutical company. Ken d'Entremont's career also includes a significant tenure at sanofi-aventis from 1984 to 1999, where responsibilities included Vice President of Business Development and Vice President of Sales and Marketing. Ken d'Entremont holds a Bachelor of Science degree in Chemistry from McMaster University, earned between 1980 and 1984.